{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:19:04Z","timestamp":1794712744497,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Foundation of Pathologic Research Centre of the China Academy of Medical Sciences","award":["2015PT320009"],"award-info":[{"award-number":["2015PT320009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13000-016-0548-5","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T05:31:44Z","timestamp":1476855104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinicopathological features and BRAFV600E mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis"],"prefix":"10.1186","volume":"11","author":[{"given":"Zhen","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingrong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,19]]},"reference":[{"key":"548_CR1","first-page":"358","volume-title":"WHO classification of tumours the haematopoietic and lymphoid tissues","author":"R Jaffe","year":"2008","unstructured":"Jaffe R, Weiss LM, Facchetti F. Tumours derived from Langerhans cells. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours the haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 358\u201360."},{"key":"548_CR2","first-page":"193","volume-title":"WHO classification of tumours the central nervous system","author":"W Paulus","year":"2007","unstructured":"Paulus W, Perry A. Histiocytic tumours. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumours the central nervous system. Lyon: IARC Press; 2007. p. 193\u20136."},{"issue":"4","key":"548_CR3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/pbc.24042","volume":"58","author":"B Fahrner","year":"2012","unstructured":"Fahrner B, Prosch H, Minkov M, Krischmann M, Gadner H, Prayer D, et al. Long-term outcome of hypothalamic pituitary tumors in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2012;58(4):606\u201310.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"548_CR4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1210\/jcem.85.4.6501","volume":"85","author":"GA Kaltsas","year":"2000","unstructured":"Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, et al. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab. 2000;85(4):1370\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"548_CR5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12185-011-0955-z","volume":"94","author":"S Imashuku","year":"2011","unstructured":"Imashuku S, Kudo N, Kaneda S, Kuroda H, Shiwa T, Hiraiwa T, et al. Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis. Int J Hematol. 2011;94(6):556\u201360.","journal-title":"Int J Hematol"},{"issue":"3","key":"548_CR6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s12020-014-0408-6","volume":"48","author":"N Kurtulmus","year":"2015","unstructured":"Kurtulmus N, Mert M, Tanakol R, Yarman S. The pituitary gland in patients with Langerhans cell histiocytosis: a clinical and radiological evaluation. Endocrine. 2015;48(3):949\u201356.","journal-title":"Endocrine"},{"issue":"2","key":"548_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.endonu.2014.10.004","volume":"62","author":"S Toro Galv\u00e1n","year":"2015","unstructured":"Toro Galv\u00e1n S, Planas Vilaseca A, Michalopoulou Alevras T, Torres D\u00edaz A, Su\u00e1rez Balaguer J, Villabona Artero C. Endocrine changes in histiocytosis of the hypothalamic-pituitary axis. Endocrinol Nutr. 2015;62(2):72\u20139.","journal-title":"Endocrinol Nutr"},{"issue":"3","key":"548_CR8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s12020-014-0497-2","volume":"48","author":"P Makras","year":"2015","unstructured":"Makras P, Kaltsas G. Langerhans cell histiocytosis and pituitary function. Endocrine. 2015;48(3):728\u20139.","journal-title":"Endocrine"},{"issue":"4","key":"548_CR9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11102-010-0233-8","volume":"13","author":"MS Garc\u00eda Gallo","year":"2010","unstructured":"Garc\u00eda Gallo MS, Mart\u00ednez MP, Abalovich MS, Guti\u00e9rrez S, Guitelman MA. Endocrine manifestations of Langerhans cell histiocytosis diagnosed in adults. Pituitary. 2010;13(4):298\u2013303.","journal-title":"Pituitary"},{"issue":"9","key":"548_CR10","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1210\/jc.2011-0513","volume":"96","author":"I Marchand","year":"2011","unstructured":"Marchand I, Barkaoui MA, Garel C, Polak M, Donadieu J, Writing Committee. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents. J Clin Endocrinol Metab. 2011;96(9):E1352\u201360.","journal-title":"J Clin Endocrinol Metab"},{"key":"548_CR11","first-page":"915716","volume":"2015","author":"J Keates-Baleeiro","year":"2015","unstructured":"Keates-Baleeiro J, Rincon M. Morbid obesity as early manifestation of occult hypothalamic-pituitary LCH with delay in treatment. Case Rep Oncol Med. 2015;2015:915716.","journal-title":"Case Rep Oncol Med"},{"issue":"7","key":"548_CR12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1515\/jpem-2015-0391","volume":"29","author":"S Nakagawa","year":"2016","unstructured":"Nakagawa S, Shinkoda Y, Hazeki D, Imamura M, Okamoto Y, Kawakami K, et al. Central diabetes insipidus as a very late relapse limited to the pituitary stalk in Langerhans cell histiocytosis. J Pediatr Endocrinol Metab. 2016;29(7):873\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"548_CR13","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919\u201323.","journal-title":"Blood"},{"issue":"4","key":"548_CR14","doi-asserted-by":"crossref","first-page":"e33891","DOI":"10.1371\/journal.pone.0033891","volume":"7","author":"T Satoh","year":"2012","unstructured":"Satoh T, Smith A, Sarde A, Lu HC, Mian S, Trouillet C, et al. B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease. PLoS One. 2012;7(4):e33891.","journal-title":"PLoS One"},{"issue":"12","key":"548_CR15","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1182\/blood-2012-06-429597","volume":"120","author":"F Sahm","year":"2012","unstructured":"Sahm F, Capper D, Preusser M, Meyer J, Stenzinger A, Lasitschka F, et al. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood. 2012;120(12):e28\u201334.","journal-title":"Blood"},{"issue":"6","key":"548_CR16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/WCO.0000000000000146","volume":"27","author":"AS Berghoff","year":"2014","unstructured":"Berghoff AS, Preusser M. BRAF alterations in brain tumours: molecular pathology and therapeutic opportunities. Curr Opin Neurol. 2014;27(6):689\u201396.","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"548_CR17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/PAS.0000000000000129","volume":"38","author":"AC Roden","year":"2014","unstructured":"Roden AC, Hu X, Kip S, Parrilla Castellar ER, Rumilla KM, Vrana JA, et al. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol. 2014;38(4):548\u201351.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"548_CR18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/2159-8290.CD-14-0742","volume":"5","author":"DM Hyman","year":"2015","unstructured":"Hyman DM, Diamond EL, Vibat CR, Hassaine L, Poole JC, Patel M, et al. Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders. Cancer Discov. 2015;5(1):64\u201371.","journal-title":"Cancer Discov"},{"issue":"9","key":"548_CR19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","volume":"121","author":"J Haroche","year":"2013","unstructured":"Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 2013;121(9):1495\u2013500.","journal-title":"Blood"},{"issue":"2","key":"548_CR20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/his.12416","volume":"65","author":"H Go","year":"2014","unstructured":"Go H, Jeon YK, Huh J, Choi SJ, Choi YD, Cha HJ, et al. Frequent detection of BRAF (V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology. 2014;65(2):261\u201372.","journal-title":"Histopathology"},{"issue":"7","key":"548_CR21","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1200\/JCO.1996.14.7.2073","volume":"14","author":"B Willis","year":"1996","unstructured":"Willis B, Ablin A, Weinberg V, Zoger S, Wara WM, Matthay KK. Disease course and late sequelae of Langerhans\u2019 cell histiocytosis: 25- year experience at the University of California, San Francisco. J Clin Oncol. 1996;14(7):2073\u201382.","journal-title":"J Clin Oncol"},{"issue":"4","key":"548_CR22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00314840","volume":"19","author":"D Belen","year":"1996","unstructured":"Belen D, Colak A, Ozcan O. CNS involvement of Langerhans cell histiocytosis: report of 23 surgically treated cases. Neurosurg Rev. 1996;19(4):247\u201352.","journal-title":"Neurosurg Rev"},{"issue":"2","key":"548_CR23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/02688690500145944","volume":"19","author":"C Rodriguez-Pereira","year":"2005","unstructured":"Rodriguez-Pereira C, Borras-Moreno JM, Pesudo-Martinez JV, Vera-Roman JM. Cerebral solitary Langerhans cell histiocytosis: report of two cases and review of the literature. Br J Neurosurg. 2005;19(2):192\u20137.","journal-title":"Br J Neurosurg"},{"issue":"1","key":"548_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12020-014-0184-3","volume":"47","author":"F Jian","year":"2014","unstructured":"Jian F, Bian L, Sun S, Yang J, Chen X, Chen Y, et al. Surgical biopsies in patients with central diabetes insipidus and thickened pituitary stalks. Endocrine. 2014;47(1):325\u201335.","journal-title":"Endocrine"},{"issue":"3","key":"548_CR25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10014-011-0034-4","volume":"28","author":"S Noh","year":"2011","unstructured":"Noh S, Kim DS, Kim J, Kim SH. Langerhans cell histiocytosis in endoscopic biopsy: marked pinching artifacts by endoscopy. Brain Tumor Pathol. 2011;28(3):285\u20139.","journal-title":"Brain Tumor Pathol"},{"key":"548_CR26","first-page":"6365830","volume":"2016","author":"W Liu","year":"2016","unstructured":"Liu W, Wang L, Liu M, Li G. Pituitary morphology and function in 43 children with central diabetes insipidus. Int J Endocrinol. 2016;2016:6365830.","journal-title":"Int J Endocrinol"},{"issue":"5","key":"548_CR27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00277-016-2606-1","volume":"95","author":"XX Cao","year":"2016","unstructured":"Cao XX, Sun J, Li J, Zhong DR, Niu N, Duan MH, et al. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults. Ann Hematol. 2016;95(5):745\u201350.","journal-title":"Ann Hematol"},{"issue":"4","key":"548_CR28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/107327481402100409","volume":"21","author":"N Grana","year":"2014","unstructured":"Grana N. Langerhans cell histiocytosis. Cancer Control. 2014;21(4):328\u201334.","journal-title":"Cancer Control"},{"issue":"5","key":"548_CR29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.clineuro.2012.07.004","volume":"115","author":"WC Hong","year":"2013","unstructured":"Hong WC, Murovic J, Gibbs I, Vogel H, Chang SD. Pituitary stalk Langerhans cell histiocytosis treated with CyberKnife radiosurgery. Clin Neurol Neurosurg. 2013;115(5):573\u20137.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"548_CR30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1096-911X(199707)29:1<36::AID-MPO7>3.0.CO;2-T","volume":"29","author":"KE Rosenzweig","year":"1997","unstructured":"Rosenzweig KE, Arceci RJ, Tarbell NJ. Diabetes insipidus secondary to Langerhans\u2019 cell histiocytosis: is radiation therapy indicated? Med Pediatr Oncol. 1997;29(1):36\u201340.","journal-title":"Med Pediatr Oncol"},{"issue":"12","key":"548_CR31","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.18632\/oncotarget.2061","volume":"5","author":"AM Bubolz","year":"2014","unstructured":"Bubolz AM, Weissinger SE, Stenzinger A, Arndt A, Steinestel K, Br\u00fcderlein S, et al. Potential clinical implications of BRAF mutations in histiocytic proliferations. Oncotarget. 2014;5(12):4060\u201370.","journal-title":"Oncotarget"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-016-0548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T19:31:42Z","timestamp":1568489502000},"score":1,"resource":{"primary":{"URL":"http:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-016-0548-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1186\/s13000-016-0548-5","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,19]]},"article-number":"100"}}